Adjuvant transarterial chemoembolization after curative resection of hepatocellular carcinoma: A non-randomized comparative study

Hepato-Gastroenterology

Volumn 59, Issue 116, 2012, Pages 1198-1203

  Xi, Tao ^a   Lai, Eric C H ^b   Min, An Ru ^a   Shi, Le Hua ^a   Wu, Dong ^a   Xue, Feng ^a   Wang, Kui ^a   Yan, Zhenlin ^a   Xia, Yong ^a   Shen, Feng ^a   Lau, Wan Yee ^a,b   Wu, Meng Chao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Prince of Wales Hospital   (Hong Kong)

Author keywords

Adjuvant therapy; Hepatectomy; Hepatocellular carcinoma; Liver neoplasm; Therapeutic embolization

Indexed keywords

ADOLESCENT; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CHEMOEMBOLIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RISK FACTOR; TRANSARTERIAL CHEMOEMBOLIZATION; TUMOR RECURRENCE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84861364378     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge09654     Document Type: Article

References (30)

1. Leong TY, Leong AS: Epidemiology. In Lau WY, ed. Hepatocellular carcinoma. World Scientific Publishing Co. Pt. Ltd., Singapore; 2008:1-24.
2. Lai EC, Lau WY: The continuing challenge of hepatic cancer in Asia. Surgeon 2005; 3:210-5.
3. Lau WY: Primary hepatocellular carcinoma. In: Blumgart LH, Fong Y, eds. Surgery of the Liver and Biliary Tract. Vol. 2. London: WB Saunders; 2000:1423-1450.
4. Lau WY: Management of hepatocellular carcinoma. J R Coll Surg Edinb 2002; 47:389-399.
5. Lau WY, Lai EC: Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008; 7:237-57.
6. Belghiti J: Surgical treatment. In: Lau WY, ed. Hepatocellular Carcinoma. Singapore: World Scientific Publishing Co Ltd; 2008:387-408.
7. Lau WY, Lai EC: The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 2009; 249:20-25.
8. Lau WY, Yu SC, Lai EC, Leung TW: Transarterial chemoembolization for hepatocellular carcinoma. J Am Coll Surg 2006; 202:155-168.
9. Lau WY, Lai EC: Neoadjuvant/adjuvant/chemoprevention therapy and tumor downstaging. In: Lau WY, ed. Hepatocellular Carcinoma. Singapore: World Scientific Publishing Co Ltd; 2008:709-737.
10. Lau WY, Lai EC, Lau SH: The current role of neoadjuvant/adjuvant/ chemoprevention therapy in partial hepatectomy for hepatocellular carcinoma: a systematic review. Hepatobiliary Pancreat Dis Int 2009; 8:124-133.
11. Chan ES, Chow PK, Tai B, et al.: Neoadjuvant and adjuvant therapy for operable hepatocellular carcinoma. Cochrane Database Syst Rev 2000:CD001199.
12. Schwartz JD, Schwartz M, Mandeli J, et al.: Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials. Lancet Oncol 2002; 3:593-603.
13. Wong IH, Leung T, Ho S, Lau WY, Chan M, Johnson PJ: Semi-quantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. Br J Cancer 1997; 76:628-633.
14. Wong IH, Lau WY, Leung T, Yeo W, Johnson PJ: Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: a quantitative analysis. Clin Cancer Res 1999; 5:4021-4027.
15. Wong IH, Yeo W, Leung T, Lau WY, Johnson PJ: Circulating tumor cell mRNAs in peripheral blood from hepatocellular carcinoma patients under radiotherapy, surgical resection or chemotherapy: a quantitative evaluation. Cancer Lett 2001; 167:183-191.
16. Asahara T, Itamoto T, Katayama K, et al.: Adjuvant hepatic arterial infusion chemotherapy after radical hepatectomy for hepatocellular carcinoma-results of long-term follow-up. Hepatogastroenterol 1999; 46:1042-1048.
17. Nakashima K, Kitano S, Kim YI, Aramaki M, Kawano K: Postoperative adjuvant arterial infusion chemotherapy for patients with hepatocellular carcinoma. Hepato-gastroenterol 1996; 43:1410-1414.
18. Tanaka K, Shimada H, Togo S, Takahashi T, Endo I, Sekido H, Yoshida T: Use of transcatheter arterial infusion of anticancer agents with lipiodol to prevent recurrence of hepatocellular carcinoma after hepatic resection. Hepato-gastroenterol 1999; 46:1083-1088.
19. Shimoda M, Bando T, Nagata T, Shirosaki I, Sakamoto T, Tsukada K: Prophylactic chemolipiodolization for postoperative hepatoma patients. Hepato-gastroenterol 2001; 48:493-497.
20. Niguma T, Mimura T, Tutui N: Adjuvant arterial infusion chemotherapy after resection of hepatocellular carcinoma with portal thrombosis: a pilot study. J Hepatobiliary Pancreat Surg 2005; 12:249-253.
21. Ren ZG, Lin ZY, Xia JL, et al.: Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: a retrospective control study. World J Gastroenterol 2004; 10:2791-2794.
22. Cheng HY, Wang X, Chen D, Xu AM, Jia YC: The value and limitation of transcatheter arterial chemoembolization in preventing recurrence of resected hepatocellular carcinoma. World J Gastroenterol 2005; 11:3644-3646.
23. Izumi R, Shimizu K, Iyobe T, et al.: Postoperative adjuvant hepatic arterial infusion of Lipiodol containing anticancer drugs in patients with hepatocellular carcinoma. Hepatology 1994; 20:295-301.
24. Li JQ, Zhang YQ, Zhang WZ, Yuan Yf, Li GH: Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J Cancer Res Clin Oncol 1995; 121:364-366.
25. Ueno S, Tanabe G, Yoshida A, Yoshidome S, Takao S, Aikou T: Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histological activity of hepatitis. Cancer 1999; 86:248-254.
26. Peng BG, He Q, Li JP, Zhou f: Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. Am J Surg 2009; 198(3):313-318.
27. Zhong C, Guo RP, Li JQ, Shi M, Wei W, Chen MS, Zhang YQ: A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma. J Cancer Res Clin Oncol 2009; 135(10):1437-1445.
28. Lai EC, Lo CM, fan ST, Liu CL, Wong J: Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 1998; 133:183-188.
29. Ono T, Nagasue N, Kohno H, et al.: Adjuvant chemotherapy with epirubicin and carmofur after radical resection of hepatocellular carcinoma: a prospective randomized study. Semin Oncol 1997; 24:S6.18-25.
30. Ono T, Yamanoi A, Nazmy El Assal O, Kohno H, Nagasue N: Adjuvant chemotherapy after resection of hepatocellular carcinoma causes deterioration of long-term prognosis in cirrhotic patients: meta-analysis of three randomized controlled trials. Cancer 2001; 91:2378-2385.